Treatment for Lung Cancer - Jay Lee, MD and Jonathan Goldman, MD - UCLAMDChat

Explore the latest surgical and nonsurgical treatments for lung cancer in this informative UCLA MDChat featuring cardiothoracic surgeon Dr. Jay Lee and hematologist/oncologist Dr. Jonathan Goldman. Gain insights into lung cancer staging and its crucial role in treatment planning. Delve into topics such as lung cancer incidence, histology, risk factors, and diagnostic work-up. Learn about TNM staging, surgical options, and outcomes. Discover advanced treatments like radiofrequency ablation and targeted therapies for specific mutations. Understand the molecular basis of resistance and the potential of immunotherapy, including immune checkpoint inhibition and PD1 inhibitors in non-small cell lung cancer (NSCLC).

Intro
Lung Cancer Incidence and deaths
Lung Cancer Histology
Lung Cancer Presenting symptoms
Lung Cancer Risk factors
Lung Cancer When to initiate work-up
Lung Cancer TNM Staging
Lung Cancer Staging
Lung Cancer Mediastinal staging
Lung Cancer Surgery
Lung Cancer Surgical outcomes
Radiofrequency ablation of lung tumors
Lung Cancer Subtypes
Advanced NSCLC. Stage IV
NSCLC Chemo approaches by histology
Targeting specific mutations
Small molecule inhibitors treat specific proteins
Receptors and specific inhibitors
IPASS: response rates by mutation status
Incidence of Single Driver Mutations
Clinical Responses and Resistance
Molecular Basis of Resistance
Immunotherapy
Immune Checkpoint inhibition
PD1 Inhibitor in NSCLC